Hein Heidbuchel, Marco Alings and Paulus Kirchhof discuss the management of NOACs in daily practice.
Apart from the study results, are all NOACs equal for everyday use? What do we have to consider when deciding on the dose? How long to stop in anticipation of a procedure, and what to do in case of bleeding? Prescription-and-go, or do we need to follow-up on those NOAC patients, and how? And what to do if there is an indication for both an antiplatelet drug and anticoagulation? You certainly have pondered over these questions. Our faculty will try to provide you with answers.
Novel Oral Anticoagulants for Atrial FibrillationNOAC for AF Practical Guide
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
The EHRA Webinars are designed to help you improve your daily practice!The format includes a case based presentation, online assesssment and live discussions with the 3 key opinion leaders who will give you some useful tips for your daily clinical practice.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Bayer in the form of unrestricted educational grants. The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.